Aculys Pharma Delivers Positive Results in Domestic Phase III Clinical Trial of Pitolisant for Narcolepsy Patients

Aculys completed the double-blind portion of a Phase 3 trial in Japan for the use of pitolisant in narcolepsy patients. In the study, the primary efficacy endpoint was achieved, and the study confirmed that the safety and tolerability of pitolisant were comparable to those observed in overseas clinical trials. Based on the study results, Aculys […]